Dr. Rohit Varma, MD

Dr. Varma practices at CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems.

Dr. Varma's NPI, 1073670212, was assigned on January 3, 2007. Dr. Varma graduated from Maulana Azad Medical College in 1986. Dr. Varma holds California license A52885.

Dr. Varma's primary practice is CHA Hollywood Presbyterian Medical Center, at 1300 N Vermont Ave, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (213) 413-3000.

Dr. Varma's primary practice is CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems. Dmand AI also links Dr. Varma to 3 medical groups, 2 group practices and clinics and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varma practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Varma's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Varma is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Varma's licenses on file in 3 states: California, Illinois and Maryland.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, glaucoma, glaucoma surgery and secondary membranaous cataract surgery among the conditions Dr. Varma treats.

CMS data shows 2,698 Medicare services from Dr. Varma across 13 procedure codes in 2024, for 602 Medicare patients. Medicare paid $235,102 for them.

CMS counts 602 Medicare patients who saw Dr. Varma in 2024. The largest group is 65 to 74, with 245 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Varma's median patient age at 66, with 54% women.

In 2024, Dr. Varma wrote 8,347 Medicare Part D claims for 975 patients. 49% of them were for generic drugs. CMS names the drug for 8,243 of them, across 33 drugs with 11 or more claims each, at $1,076,202 in total drug cost. In 2023, CMS named 7,584 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Varma for performance year 2024, reported individually. Dr. Varma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Varma as offering telehealth. CMS counts 29 procedures of cataract surgery by Dr. Varma, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 90 papers to Dr. Varma, published from 2003 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Gene Frequency, Genetic Predisposition to Disease and Genetic Variation. Dr. Varma has published most often in Nat Genet. Dr. Varma's most frequent co-authors are David S. Greenfield, MD, Joel S. Schuman, MD and Grace Marie Richter, MD.

Dmand AI links Dr. Varma to 2 clinical trials. Conditions studied include Glaucoma, Strabismus and Amblyopia.

CMS Open Payments shows 104 general payments to Dr. Varma from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Genentech, Inc. paid the most, $32,047. It also lists 6 research payments totaling $3,942 from 2016 to 2020.

Dmand AI lists 8 awards for Dr. Varma, most recently Top Doctors in 2018. Dr. Varma serves on Awards Committee ARVO.

Dr. Varma graduated from Maulana Azad Medical College in 1986. Dr. Varma is a member of AAO, Association for Research in Vision and Ophthalmology, CMA and Glaucoma Research Society.

Dr. Varma is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.